The global interventional oncology market size was US$ 2.1 billion in 2021. The global interventional oncology market size is forecast to reach US$ 3.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2022 to 2030.

Interventional oncology (IO) is an emerging subspecialty that focuses on using image-guided procedures (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. The three key areas of cancer intervention that IO focuses on are therapy, diagnosis, and symptom relief. Advances in cross-sectional imaging modalities like ultrasound, magnetic resonance (MR), computed tomography (CT), and positron emission tomography (PET) have enabled progress in IO (PET).

Factors Influencing Market Growth
Among the factors driving the global market include growing cancer cases worldwide.
The rising advantages of minimally invasive surgical procedures, technical advances in interventional oncology, and rising government funding for oncology procedures fuel the global market growth.
The lack of understanding of interventional oncology across low or middle-income countries may slow down the overall market growth.

Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide implemented a lockdown in order to curb the spread of the COVID-19 virus. This disrupted both sellers' and purchasers' demands. In addition, the COVID-19 pandemic has had a significant impact on IO activity in cancer centers and hospitals. Clinics and hospitals in the majority of countries have converted their operating rooms into intensive care units (ICUs) and mobilized oncologists to combat the COVID-19 patients. These factors have had a negative impact on the worldwide interventional oncology industry.

Regional Analysis
North America garnered the major share of the global market in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing population with chronic cancer such as hepatocellular carcinoma, lung cancer, renal cancer, and metastatic colorectal cancer. In addition, substantial adoption of minimally invasive surgeries for the adequate management of cancer, well-established healthcare infrastructure, and increasing adoption of technologically advanced interventional oncology products. Thus, these factors fule the market growth in the region.

The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the increased prevalence of cancer in the high population countries such as India and China, rapidly transforming healthcare systems, diverse government initiatives to enhance overall healthcare, and growing per capita healthcare expenditure. In addition, increasing investments by leading global interventional oncology companies are forecast to drive the market growth in the region.

Leading Competitors
The leading prominent companies profiled in the global interventional oncology market are:
Medtronic, Incorporated
Boston Scientific Corporation
Becton, Dickinson, and Company
Terumo Corporation
Merit Medical
AngioDynamics
Johnson & Johnson
Teleflex Incorporated
Cook Group
HealthTronics, Incorporated
Other Prominent Players

Scope of the Report
The global interventional oncology market segmentation focuses on Product Type, Cancer Type, End-User, and Region.
Segmentation based on Product Type
Embolization Devices
Ablation Devices
Support Devices
Segmentation based on Cancer Type
Liver Cancer
Lung Cancer
Breast Cancer
Prostate Cancer
Kidney Cancer
Bone Metastasis
Other Cancers
Segmentation based on End-User
Hospitals
Ambulatory Surgery Centers
Research and Academic Institutes
Segmentation based on Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Meta Title: Interventional Oncology Market Size, Share, Insight and Forecast 2022 To 2030
Meta Description: Global Interventional Oncology Market is projected to reach US$ 3.8 billion by end of 2030 from US$ 2.1 billion in 2021, at a CAGR of 6.5%
Meta Keywords: interventional oncology market Size, interventional oncology market share, interventional oncology market trend, interventional oncology market Forecast, interventional oncology market insight